Could we apply the criteria of DAWN and DEFUSE-3 trials for slow progressors, beyond 24 h?
Delvoye, François, Desilles, Jean-Philippe, Mazighi, MikaelJournal:
Acta Neurologica Belgica
DOI:
10.1007/s13760-020-01277-7
Date:
January, 2020
File:
PDF, 681 KB
2020